Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Recent Articles in Industry Insights

China Generic Drugmakers Poaching Indian Execs
Sep 3, 2015
In the competition between China and India pharmas, China's generic drug industry leads in the supply of APIs to global drugmakers, but India supplies more finished generic drugs to the world's marketplace. That may be changing. According to press reports, China drugmakers have begun hiring experienced Indian pharma execs, offering them two to three times their present salaries. The China companies are willing to pay at these levels because the Indian professionals have two skills the Chinese want: drug formulation experience and English. China's drugmakers want help as they target the western world's lucrative generic drug market. More details....

Share this with colleagues:  

China Halts IPOs in Move to Stop Stock Market Decline
Jul 6, 2015
China ordered a halt to new IPOs on its two domestic exchanges, Shanghai and Shenzhen. The move seeks to stop a precipitous month-long decline of over 30% in the exchange indexes, including a 7% drop last Friday. The government hopes the hiatus in new offerings will encourage investors to hold on to their present holdings, rather than selling them to buy new offerings. In addition, the nation's largest stock brokerage companies agreed to buy $19.3 billion worth of stock in already public companies, another move that could support stock prices. More details....

Share this with colleagues:  

Chronic Disease Rises Sharply in China
Jul 1, 2015
Fully 25% of China's adult population suffer from hypertension and almost 10% have diabetes. The analysis was part of a ten-year study conducted by China's National Health and Family Planning Commission. Chronic diseases result from poor dietary habits, sedentary life styles and smoking, the report continued, though longer average lifespans also have an effect. The government plans an all-out education offensive to prevent the occurrence of chronic disease, and it pledged to develop best-practice use of western-style drugs and TCM products to treat chronic disease, once it occurs. More details....

Share this with colleagues:  

China Making Its Mark in Global Biopharma Patent Filings
Jun 10, 2015
Innovation is on the rise in China's Biotech and Pharma sectors, according to a survey of patent filings and patent approvals conducted by Thomson Reuters. Of all the institutions/ companies filing patents globally in 2014, China is home to three of the top five Biotech filing institutions and two of the top five Pharma filing entities. Globally, the number of filings/approvals climbed just 3% last year in all sectors. The Biotech and Pharma sectors, however, are much stronger than the overall average, and the difference seems to have been China's rising contribution. More details....

Share this with colleagues:  

In China, Big Pharma Faces Drug Pricing Pressure
Jun 1, 2015
Today, June 1, China will end the official caps on most drug prices. Although the administrative change may sound like a major reform, the actual effect will be almost nil. For most drugs in China, most of which are generics, the price is actually set by the province-by-province auctions. By being one of the one or two lowest bidders, a pharma company is allowed to sell its products through hospital pharmacies. However, for multinational pharmas in China, whose premium prices have been protected from the auction process, the situation is quite different. More details....

Share this with colleagues:  

More Articles >>
Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here